| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Brigitta Bond. Common genetic factors for depression and cardiovascular disease. Dialogues in clinical neuroscience. vol 9. issue 1. 2007-06-26. PMID:17506223. |
the first promising results were obtained with the serotonin transporter, and it may be hypothesized that this polymorphism interacts via the impact of the s allele on depression and via the effect of the l allele on platelet activation. |
2007-06-26 |
2023-08-12 |
Not clear |
| Demian Halperin, Guido Rebe. Influence of antidepressants on hemostasis. Dialogues in clinical neuroscience. vol 9. issue 1. 2007-06-26. PMID:17506225. |
antidepressants, particularly selective serotonin reuptake inhibitors (ssris), are widely used for the treatment of depression and anxious disorders. |
2007-06-26 |
2023-08-12 |
Not clear |
| Demian Halperin, Guido Rebe. Influence of antidepressants on hemostasis. Dialogues in clinical neuroscience. vol 9. issue 1. 2007-06-26. PMID:17506225. |
the observation that depression is an independent risk factor for cardiovascular mortality and morbidity in patients with ischemic heart disease, the assessment of the central role of serotonin in pathophysiological mechanisms of depression, and reports of cases of abnormal bleeding associated with antidepressant therapy have led to investigations of the influence of antidepressants on hemostasis markers. |
2007-06-26 |
2023-08-12 |
Not clear |
| Alain Ronso. [Neurotrophic theories of stress and neurobiology of antidepressants: applications in psycho-oncology]. Bulletin du cancer. vol 94. issue 5. 2007-06-20. PMID:17535780. |
in this paper, we travel back to the origins of antidepressant action theories, with the monoaminergic hypothesis, that revealed the role of serotonin and norepinephrine in the physiopathology of depression. |
2007-06-20 |
2023-08-12 |
Not clear |
| Ridha Joober, Sarojini Sengupta, Norbert Schmit. Serotonin transporter, stressful life events, and depression severity. The American journal of psychiatry. vol 164. issue 5. 2007-06-18. PMID:17475746. |
serotonin transporter, stressful life events, and depression severity. |
2007-06-18 |
2023-08-12 |
Not clear |
| Victor Serebruany, Alex Malinin, Vadim Dragan, Dan Atar, Louis van Zyl, Anatoly Draga. Fluorimetric quantitation of citalopram and escitalopram in plasma: developing an express method to monitor compliance in clinical trials. Clinical chemistry and laboratory medicine. vol 45. issue 4. 2007-06-14. PMID:17439330. |
selective serotonin reuptake inhibitors (ssris) in general, and citalopram/escitalopram in particular, are widely used to treat clinical depression. |
2007-06-14 |
2023-08-12 |
human |
| Roland Mergl, Oliver Pogarell, Georg Juckel, Julian Rihl, Verena Henkel, Thomas Frodl, Florian Müller-Siecheneder, Max Karner, Peter Tigges, Andreas Schröter, Ulrich Heger. Hand-motor dysfunction in depression: characteristics and pharmacological effects. Clinical EEG and neuroscience. vol 38. issue 2. 2007-06-14. PMID:17515173. |
using this tool, we aimed to investigate fine motor performance in patients suffering from depression and to compare a selective noradrenaline re-uptake inhibitor (nari) (reboxetine) and a selective serotonin reuptake inhibitor (ssri) (citalopram) regarding motor side effects after 4 weeks of treatment. |
2007-06-14 |
2023-08-12 |
human |
| Marilyn J Duncan, Kathleen M Frankli. Expression of 5-HT7 receptor mRNA in the hamster brain: effect of aging and association with calbindin-D28K expression. Brain research. vol 1143. 2007-06-13. PMID:17300762. |
aging affects several processes modulated by the 5-ht(7) receptor subtype, including circadian rhythms, learning and memory, and depression. |
2007-06-13 |
2023-08-12 |
Not clear |
| Jay D Amsterdam, Justine Shults, Nancy Rutherford, Stanley Schwart. Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus. Neuropsychobiology. vol 54. issue 4. 2007-06-13. PMID:17337914. |
selective serotonin reuptake inhibitors (ssris) may improve glycemic control and may be beneficial for patients with co-morbid depression and diabetes. |
2007-06-13 |
2023-08-12 |
Not clear |
| Allan V Kalueff, M Wheaton, R Ren-Patterson, D L Murph. Brain-derived neurotrophic factor, serotonin transporter, and depression: comment on Kaufman et al. Biological psychiatry. vol 61. issue 9. 2007-06-06. PMID:16952335. |
brain-derived neurotrophic factor, serotonin transporter, and depression: comment on kaufman et al. |
2007-06-06 |
2023-08-12 |
Not clear |
| Yan Leykin, Jay D Amsterdam, Robert J DeRubeis, Robert Gallop, Richard C Shelton, Steven D Hollo. Progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. Journal of consulting and clinical psychology. vol 75. issue 2. 2007-06-01. PMID:17469884. |
progressive resistance to a selective serotonin reuptake inhibitor but not to cognitive therapy in the treatment of major depression. |
2007-06-01 |
2023-08-12 |
Not clear |
| Jeffrey M Witkin, Gerard J Marek, Bryan G Johnson, Darryle D Schoep. Metabotropic glutamate receptors in the control of mood disorders. CNS & neurological disorders drug targets. vol 6. issue 2. 2007-05-29. PMID:17430147. |
for example, mglu receptor modulation can facilitate neuronal stem cell proliferation (neurogenesis) and the release of neurotransmitters that are associated with treatment response to depression in humans (serotonin, norepinephrine, dopamine). |
2007-05-29 |
2023-08-12 |
Not clear |
| A Serrano-Blanco, A Pinto-Meza, D Suárez, M T Peñarrubia, J M Har. Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia. Acta psychiatrica Scandinavica. Supplementum. issue 432. 2007-05-25. PMID:17087814. |
cost-utility of selective serotonin reuptake inhibitors for depression in primary care in catalonia. |
2007-05-25 |
2023-08-12 |
Not clear |
| K P Lesch, R Mössne. Inactivation of 5HT transport in mice: modeling altered 5HT homeostasis implicated in emotional dysfunction, affective disorders, and somatic syndromes. Handbook of experimental pharmacology. issue 175. 2007-05-23. PMID:16722245. |
as an example, inactivation of the serotonin (5ht) transporter (5htt, slc6a4) gene in mice expanded our view of adaptive 5ht uptake regulation and maintenance of 5ht homeostasis in the developing human brain and molecular processes underlying anxiety-related traits, as well as affective spectrum disorders including depression. |
2007-05-23 |
2023-08-12 |
mouse |
| K P Lesch, R Mössne. Inactivation of 5HT transport in mice: modeling altered 5HT homeostasis implicated in emotional dysfunction, affective disorders, and somatic syndromes. Handbook of experimental pharmacology. issue 175. 2007-05-23. PMID:16722245. |
moreover, demonstration of a joint influence of the 5htt variation and environmental sources during early brain development advanced our understanding of the mechanism of genexgene and genexenvironment interactions in the developmental neurobiology of anxiety and depression. |
2007-05-23 |
2023-08-12 |
mouse |
| Stephen S Gottlieb, Willem J Kop, Sue A Thomas, Scott Katzen, Mark R Vesely, Nancy Greenberg, Joanne Marshall, Michelle Cines, Stacey Minshal. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. American heart journal. vol 153. issue 5. 2007-05-22. PMID:17452166. |
because the response to depression treatment has not been evaluated in this patient population, we evaluated the efficacy of controlled-release paroxetine (paroxetine cr), a selective serotonin reuptake inhibitor, on depression and quality of life in chronic heart failure. |
2007-05-22 |
2023-08-12 |
Not clear |
| M Guttman, I Boileau, J Warsh, J A Saint-Cyr, N Ginovart, T McCluskey, S Houle, A Wilson, E Mundo, P Rusjan, J Meyer, S J Kis. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. European journal of neurology. vol 14. issue 5. 2007-05-21. PMID:17437611. |
early post-mortem data suggest that damage to brain serotonin neurones might play a role in some features (e.g., depression) of parkinson's disease (pd). |
2007-05-21 |
2023-08-12 |
Not clear |
| Paweł Zajdel, Gilles Subra, Andrzej J Bojarski, Beata Duszyńska, Ewa Tatarczyńska, Agnieszka Nikiforuk, Ewa Chojnacka-Wójcik, Maciej Pawłowski, Jean Martine. Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation. Bioorganic & medicinal chemistry. vol 15. issue 8. 2007-05-18. PMID:17321139. |
finally, the selected compounds 19 and 20, a 5-ht(1a) partial agonist and a full agonist, respectively, and 26, a mixed 5-ht(1a)/5-ht(2a) antagonist, were evaluated in preclinical animal models of depression and anxiety. |
2007-05-18 |
2023-08-12 |
mouse |
| Ivo F Brandes, Edward J Zuperku, Astrid G Stucke, Francis A Hopp, Danica Jakovcevic, Eckehard A E Stut. Isoflurane depresses the response of inspiratory hypoglossal motoneurons to serotonin in vivo. Anesthesiology. vol 106. issue 4. 2007-05-11. PMID:17413911. |
the authors hypothesized that if anesthetic activation of leak k+ channels caused neuronal depression in vivo, this effect could be antagonized with serotonin. |
2007-05-11 |
2023-08-12 |
Not clear |
| Olaf Schulte-Herbrüggen, Rainer Hellweg, Sabine Chourbaji, Stephanie Ridder, Christiane Brandwein, Peter Gass, Heide Hörtnag. Differential regulation of neurotrophins and serotonergic function in mice with genetically reduced glucocorticoid receptor expression. Experimental neurology. vol 204. issue 1. 2007-05-10. PMID:17208231. |
the neurotrophin and serotonin (5-ht) hypotheses of depression were studied in a mouse model of reduced glucocorticoid receptor (gr) function (gr(+/-) mice), which recently has been proven as a murine model of predisposition for depressive behaviour under stressful conditions. |
2007-05-10 |
2023-08-12 |
mouse |